Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - PDUFA
Repros Therapeutics Inc. (RPRX) Announces November 30, 2015 PDUFA Goal Date For New Drug Application 4/15/2015 3:19:07 PM
Pfizer (PFE) Provides Update On IBRANCE® (Palbociclib) 1/8/2015 10:53:41 AM
Relypsa, Inc. (RLYP) Announces Assignment Of October 21, 2015 PDUFA Date For New Drug Application For Patiromer For Oral Suspension 1/5/2015 7:02:38 AM
Pharmacyclics, Inc. (PCYC) Announces Update On IMBRUVICA® (Ibrutinib) Waldenstrom's Macroglobulinemia (WM) Submission 12/22/2014 8:19:16 AM
FDA Postpones Its Final Decision On NPS Pharmaceuticals, Inc. (NPSP)'s Natpara 10/24/2014 6:08:43 AM
FDA Delays Decision On IMPAX Laboratories, Inc. (IPXL) Parkinson's Drug RYTARY 9/18/2014 7:03:02 AM
AcelRx Pharmaceuticals (ACRX) Confirms July 27, 2014 PDUFA Date For Zalviso 7/25/2014 9:08:46 AM
Flamel Technologies (FLML) Receives Class 1 Response Designation For Second NDA 6/16/2014 11:07:22 AM
Orexigen Therapeutics, Inc. (OREX)'s Much Anticipated Weight Loss Drug NB32 Gets New PDUFA Date From The FDA 6/11/2014 5:26:58 AM
NPS Pharmaceuticals, Inc. (NPSP) Reports Change In Tentative Date Of FDA Advisory Committee Review Of Natpara® BLA To September 12 - PDUFA Date Of October 24 Remains Unchanged 6/10/2014 10:01:37 AM
Orexigen Therapeutics, Inc. (OREX) Announces June 11, 2014 PDUFA Action Date For NB32 6/2/2014 9:43:04 AM
Keryx Biopharmaceuticals (KERX) Receives Notification Of PDUFA Date Extension For Zerenex™ 5/23/2014 10:10:16 AM
Baxter International, Inc. (BAX) Provides U.S. Regulatory Update On Hyqvia, Its Investigational Subcutaneous Treatment For Primary Immunodeficiency 5/21/2014 9:10:41 AM
Alimera Sciences (ALIM) Announces New PDUFA Date For ILUVIEN® 4/14/2014 6:15:30 AM
MannKind Corporation (MNKD) Drops As The FDA Delays Decision On Inhaled Insulin Treatment 4/7/2014 7:39:18 AM